1. Home
  2. CRDF vs HNVR Comparison

CRDF vs HNVR Comparison

Compare CRDF & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • HNVR
  • Stock Information
  • Founded
  • CRDF 1999
  • HNVR 2008
  • Country
  • CRDF United States
  • HNVR United States
  • Employees
  • CRDF N/A
  • HNVR N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • HNVR Commercial Banks
  • Sector
  • CRDF Health Care
  • HNVR Finance
  • Exchange
  • CRDF Nasdaq
  • HNVR Nasdaq
  • Market Cap
  • CRDF 169.6M
  • HNVR 143.6M
  • IPO Year
  • CRDF N/A
  • HNVR 2022
  • Fundamental
  • Price
  • CRDF $3.35
  • HNVR $22.31
  • Analyst Decision
  • CRDF Strong Buy
  • HNVR Buy
  • Analyst Count
  • CRDF 4
  • HNVR 1
  • Target Price
  • CRDF $12.25
  • HNVR $22.00
  • AVG Volume (30 Days)
  • CRDF 874.0K
  • HNVR 19.3K
  • Earning Date
  • CRDF 05-08-2025
  • HNVR 07-23-2025
  • Dividend Yield
  • CRDF N/A
  • HNVR 1.79%
  • EPS Growth
  • CRDF N/A
  • HNVR N/A
  • EPS
  • CRDF N/A
  • HNVR 1.30
  • Revenue
  • CRDF $587,000.00
  • HNVR $65,041,000.00
  • Revenue This Year
  • CRDF N/A
  • HNVR N/A
  • Revenue Next Year
  • CRDF N/A
  • HNVR $13.69
  • P/E Ratio
  • CRDF N/A
  • HNVR $17.19
  • Revenue Growth
  • CRDF N/A
  • HNVR 1.13
  • 52 Week Low
  • CRDF $2.01
  • HNVR $15.92
  • 52 Week High
  • CRDF $5.64
  • HNVR $27.14
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 63.95
  • HNVR 43.58
  • Support Level
  • CRDF $2.81
  • HNVR $22.52
  • Resistance Level
  • CRDF $3.08
  • HNVR $22.98
  • Average True Range (ATR)
  • CRDF 0.20
  • HNVR 0.42
  • MACD
  • CRDF 0.08
  • HNVR -0.14
  • Stochastic Oscillator
  • CRDF 76.53
  • HNVR 0.00

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.

Share on Social Networks: